Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis — Stella

Home/Pulmonary Fibrosis/

View on ClinicalTrials.gov

Recruiting

Back to Pulmonary Fibrosis trials

Trial locations(1 site)

United States

UCLA, Los Angeles, California

Key details

Sponsor

University of California, Los Angeles

Collaborators

Boehringer Ingelheim

Enrollment target

~200 participants

Started

November 2024

Primary completion

November 2027

Age range

18 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.